Centessa Pharmaceuticals

NASDAQ: CNTA · Real-Time Price · USD
17.98
0.34 (1.93%)
At close: Aug 15, 2025, 1:21 PM

Centessa Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-235.76M -151.09M -216.21M -381.85M
Depreciation & Amortization
942K 810K 131K 33.99K
Stock-Based Compensation
33.55M 29.39M 24.96M 14.85M
Other Working Capital
26.69M -16.13M -9.18M 1.34M
Other Non-Cash Items
34.46M 6.03M -3.75M 257.85M
Deferred Income Tax
2.65M -26.63M -2.86M -6.8M
Change in Working Capital
22.1M -18.86M -2.83M -5.38M
Operating Cash Flow
-142.06M -160.34M -200.55M -136.14M
Capital Expenditures
-34K -169K -1.14M -185.98K
Cash Acquisitions
n/a n/a n/a 63.43M
Purchase of Investments
-140.53M -264.91M n/a n/a
Sales Maturities Of Investments
171.83M 138.07M n/a n/a
Other Investing Acitivies
n/a n/a 206K n/a
Investing Cash Flow
31.27M -127M -931K 63.25M
Debt Repayment
-762K n/a n/a 73.93M
Common Stock Repurchased
n/a n/a n/a -12K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.32M 310K 457K 586.14M
Financial Cash Flow
364.75M 21.12M 457K 660.07M
Net Cash Flow
255.19M -265.61M -201.44M 590.08M
Free Cash Flow
-142.09M -160.51M -201.68M -136.33M